At a glance
- Originator Bristol-Myers Squibb
- Class Antineoplastics; Carbazoles; Glucosides
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 26 Apr 2001 Phase-I clinical trials for Cancer in USA (Unknown route)